EHA Library - The official digital education library of European Hematology Association (EHA)

AUTOIMMUNE CYTOPENIAS IN PRIMARY IMMUNODEFICIENCY DISEASES: SINGLE CENTER EXPERIENCE
Author(s): ,
Turkan Patiroglu
Affiliations:
Pediatric Hematology,Erciyes University Medical Faculty,Kayseri,Turkey
,
Murat Cansever
Affiliations:
Pedıatric Immunology,Erciyes University Medical Faculty,Kayseri,Turkey
Fulya Bektas
Affiliations:
Pedıatric Immunology,Erciyes University Medical Faculty,Kayseri,Turkey
(Abstract release date: 05/18/17) EHA Library. Patıroglu T. 05/18/17; 182470; PB1756
Prof. Dr. Turkan Patıroglu
Prof. Dr. Turkan Patıroglu
Contributions
Abstract

Abstract: PB1756

Type: Publication Only

Background
.

Aims

Primary immunodeficiency diseases (PID) are associated with hematologic complications such autoimmune hemolytic anemia (AIHA) and thrombocytopenia (ITP). The most common autoimmune cytopenia is ITP. Although ITP is observed in 7.6% of patients with PID, AIHA is seen at 4.8%. Also, we aimed to present the patients who had autoimmune cytopenias and PID.

Methods

Fifty six PID patients who were followed at the Pediatric Immunology Department of Erciyes University Medical Faculty (they were analyzed genetically) were evaluated retrospectively. Autoimmune cytopenias such as ITP and AIHA were detected in 9 (%16. 07) of the patients (combined immunodeficiency:4 patients, common variable immunodeficiency: 2 patients, hyper immunoglobulin E syndrome:1 patient, X-linked lymphoproliferative :1 patient, chronic granulomatous disease:1 patient). ITP was detected in 8 of 9 patients and AIHA was also detected in 6 patients. In four patients (LRBA deficiency: 2 patients, hyper IgE syndrome:1 patient and CGD:1patient), both ITP and AIHA were observed. Immunosuppressive therapy with steroid, cyclosporine, mycophenolate mofetyl and intravenous immunoglobulin were given to all patients. Bone marrow transplantation was performed to the four patients. However, five patients died because of immunodeficiency.

Results

There is a paradoxal situation between PID and autoimmunity. The reduction of central and peripheral tolerance is held responsible for autoimmunity in PID.

Conclusion

As a conclusion, we wanted to point out autoimmune cytopenias in patients with PID and the requirement of multidisciplinary approach for treatment.

Session topic: 12. Bone marrow failure syndromes incl. PNH - Clinical

Keyword(s): Immunodeficiency

Abstract: PB1756

Type: Publication Only

Background
.

Aims

Primary immunodeficiency diseases (PID) are associated with hematologic complications such autoimmune hemolytic anemia (AIHA) and thrombocytopenia (ITP). The most common autoimmune cytopenia is ITP. Although ITP is observed in 7.6% of patients with PID, AIHA is seen at 4.8%. Also, we aimed to present the patients who had autoimmune cytopenias and PID.

Methods

Fifty six PID patients who were followed at the Pediatric Immunology Department of Erciyes University Medical Faculty (they were analyzed genetically) were evaluated retrospectively. Autoimmune cytopenias such as ITP and AIHA were detected in 9 (%16. 07) of the patients (combined immunodeficiency:4 patients, common variable immunodeficiency: 2 patients, hyper immunoglobulin E syndrome:1 patient, X-linked lymphoproliferative :1 patient, chronic granulomatous disease:1 patient). ITP was detected in 8 of 9 patients and AIHA was also detected in 6 patients. In four patients (LRBA deficiency: 2 patients, hyper IgE syndrome:1 patient and CGD:1patient), both ITP and AIHA were observed. Immunosuppressive therapy with steroid, cyclosporine, mycophenolate mofetyl and intravenous immunoglobulin were given to all patients. Bone marrow transplantation was performed to the four patients. However, five patients died because of immunodeficiency.

Results

There is a paradoxal situation between PID and autoimmunity. The reduction of central and peripheral tolerance is held responsible for autoimmunity in PID.

Conclusion

As a conclusion, we wanted to point out autoimmune cytopenias in patients with PID and the requirement of multidisciplinary approach for treatment.

Session topic: 12. Bone marrow failure syndromes incl. PNH - Clinical

Keyword(s): Immunodeficiency

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies